OREXIGEN THERAPEUTICS, INC. REGISTRATION RIGHTS WAIVER AND AMENDMENT January 6, 2008Orexigen Therapeutics, Inc. • January 7th, 2008 • Pharmaceutical preparations
Reference is made to the Second Amended and Restated Investors’ Rights Agreement (the “Investors’ Rights Agreement”), dated as of November 20, 2006, by and among Orexigen Therapeutics, Inc. (the “Company”) and the investor parties thereto (the “Holders”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Investors’ Rights Agreement.
